|
CDK19 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.923400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.375200E-01 |
| Normal-vs-Stage2 |
6.751700E-02 |
| Normal-vs-Stage3 |
3.886800E-01 |
| Normal-vs-Stage4 |
9.966600E-01 |
| Stage1-vs-Stage2 |
2.207900E-02 |
| Stage1-vs-Stage3 |
1.433630E-01 |
| Stage1-vs-Stage4 |
8.110000E-01 |
| Stage2-vs-Stage3 |
1.680190E-01 |
| Stage2-vs-Stage4 |
6.912300E-02 |
| Stage3-vs-Stage4 |
3.954600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.440000E-01 |
| Normal-vs-AfricanAmerican |
3.910600E-01 |
| Normal-vs-Asian |
9.817600E-01 |
| Caucasian-vs-AfricanAmerican |
2.495400E-01 |
| Caucasian-vs-Asian |
9.670200E-01 |
| AfricanAmerican-vs-Asian |
3.844000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.880600E-01 |
| Normal-vs-Female |
8.451800E-01 |
| Male-vs-Female |
7.468600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.108800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.152600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.299640E-01 |
| Normal-vs-Age(81-100Yrs) |
9.481800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.031800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.960100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.489800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.825390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.863210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.973000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.732200E-01 |
| Classical-VS-Follicular |
3.85849999728904E-08 |
| Classical-VS-Other |
8.706400E-01 |
| Classical-VS-Normal |
3.481000E-01 |
| Tall-VS-Follicular |
4.339700E-03 |
| Tall-VS-Other |
9.906200E-01 |
| Tall-VS-Normal |
6.692400E-01 |
| Follicular-VS-Other |
1.419190E-01 |
| Follicular-VS-Normal |
3.822100E-03 |
| Other-VS-Normal |
8.337400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.325000E-01 |
| Normal-vs-N1 |
6.707400E-01 |
| N0-vs-N1 |
3.082800E-01 |
|
|
